Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Exact Therapeutics AS

EXTX
Current price
5.5 NOK 0 NOK (0.00%)
Last closed 5.5 NOK
ISIN NO0010852213
Sector Healthcare
Industry Biotechnology
Exchange Oslo Stock Exchange
Capitalization 175 410 650 NOK
Yield for 12 month -68.57 %
1Y
3Y
5Y
10Y
15Y
EXTX
21.11.2021 - 28.11.2021

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company's ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, and immunotherapy diseases, as well as CNS diseases and gene therapy. EXACT Therapeutics AS has a collaboration with GE Healthcare for the development of a ready-to-use formulation of Sonazoid for ultrasound imaging and therapy. The company was formerly known as Phoenix Solutions AS. EXACT Therapeutics AS was founded in 2012 and is based in Oslo, Norway. Address: Østre Aker vei 19, Oslo, Norway, 0581

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures EXTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -46 480 292 NOK
Operating Margin TTM -1085224.1 %
PE Ratio
Return On Assets TTM -42.05 %
PEG Ratio
Return On Equity TTM -87.71 %
Wall Street Target Price
Revenue TTM 4 432 NOK
Book Value 1.4 NOK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM 51 696 NOK
Earnings per share -1.5 NOK
Diluted Eps TTM -1.5 NOK
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics EXTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EXTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 250:1
Payout Ratio
Last Split Date 27.07.2020
Dividend Date

Stock Valuation EXTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 39579.027
Enterprise Value EBITDA -4.0783
Price Book MRQ 3.9122

Financials EXTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EXTX

For 52 weeks

4.77 NOK 17.4 NOK
50 Day MA 6.71 NOK
Shares Short Prior Month
200 Day MA 8.65 NOK
Short Ratio
Shares Short
Short Percent